Dr. Khoa Nguyen’s research interests include human-computer interaction, pharmacoepidemiology, pharmacogenomics, and health informatics. Ultimately, his research is focused on improving patient safety through medication use from two approaches: qualitative research and quantitative research.
Dr. Nguyen performs qualitative research using human-factors engineering and human-computer interaction methods to develop and implement pharmacogenomic clinical decision supports (PGx-CDS). PGx-CDS, when implemented, can foster pharmacogenomics service to predict and prevent severe adverse drug reactions from genetic mutations.
Quantitatively, he mines health care organizations’ data and literature to identify factors that can increase the risk of adverse drug reactions. He is also interested in identifying subpopulations that can receive cost-effective genetic testing.
Dr. Nguyen joined Regenstrief Institute as a research scientist after his medical informatics fellowship at Richard L. Roudebush VA Medical Center. He earned a PharmD from the University of Michigan College of Pharmacy and a BS in biochemistry and molecular cell biology from UC Davis.